Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

SEATTLE, Washington – Beginning with the advent of percutaneous transluminal coronary angioplasty (PTCA) about 20 years ago, the interventional cardiology (IC) market has grown rapidly, fueled by relentless and impressive innovation.

Stroke prevention devices in ‘Summer in Seattle’ spotlight